Trastuzumab Completed Phase 1 Trials for Advanced Solid Tumors / Malignancies / Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00005842Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
NCT01235897MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies